GlassScriptPhysician profile
Michelle Lynn Bennett
NPI 1598726507
$1,457.82
in general payments reported to CMS, 2019-2025
23 companies · $53.03 in 2025
The $53.03 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $365 · 2021: $342 · 2022: $102 · 2023: $96.44 · 2024: $199 · 2025: $53.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $447.42 | 2019-2023 | |
| Glaxosmithkline, LLC. | $131.41 | 2019-2021 | |
| Phadia US INC. | $130.15 | 2019-2024 | Immunocap |
| Merck Sharp & Dohme LLC | $101.28 | 2021-2024 | Gardasil 9, Vaxelis, Gardasil |
| Kaleo, INC. | $98.43 | 2019-2024 | Auvi-Q |
| Cranial Technologies, INC | $78.07 | 2020-2024 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $57.60 | 2020 | |
| Sanofi-Aventis U.S. LLC | $56.69 | 2024 | |
| Seqirus USA INC | $46.58 | 2020-2023 | Flucelvax Quadrivalent |
| Sobi, INC | $41.90 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $29.44 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $28.90 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $27.28 | 2023 | Flumist Quadrivalent |
| Alk-Abello, INC | $24.13 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $22.50 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $21.70 | 2020 | |
| Dermira, INC. | $20.59 | 2020 | |
| Vertical Pharmaceuticals, LLC | $17.72 | 2019 | |
| Abbvie INC. | $17.11 | 2020 | |
| Mylan Pharmaceuticals INC. | $16.47 | 2019 | |
| Nestle Healthcare Nutrition INC. | $16.46 | 2022 | |
| Mission Pharmacal Company | $14.24 | 2019 | |
| Qiagen, LLC | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.